Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05552235
Other study ID # elbowSOFT300
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 15, 2022
Est. completion date March 2023

Study information

Verified date January 2023
Source Decathlon SE
Contact Jean HEE
Phone 07 64 35 00 45
Email jean.hee@btwin.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Decathlon has developed the Elbow soft300 which is a medical device that must be positioned around the elbow to keep a physical activity on a regular basis in case of chronic epicondylitis, pain associated with tendonitis or chronic instability. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon Elbow soft 300 product to demonstrate safety and performance of this device in a real-world setting. Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Decathlon ElbowSoft300 device and support peer-reviewed publications on products performance and safety.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date March 2023
Est. primary completion date March 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Subject is aged = 18 years old - Subject has a chronic epicondylitis (>3 months) OR elbow pain associated with tendonitis OR chronic elbow instability (>3 months) - The current condition of his/her elbow allows the subject to continue usual physical activity - Subject has been informed and is willing to sign an informed consent form - Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks) - Subject is affiliated to the French social security regime Exclusion Criteria: - Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent - Subject has worn a support (elbow brace or articulated orthosis) in the last month during his/her sport practice - Subject has any medical condition that could impact the study at investigator's discretion - Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastodiene, polyester, elastane) - Adult subject to legal protection measure

Study Design


Intervention

Device:
Elbow SOFT 300
15 patients will be included in this group and will used the medical device ElbowSOFT 300 during sport practice (at least 2 sport sessions per week), for 6 weeks.
Other:
Control group
15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device), for at least 2 sport sessions per week during 6 weeks.

Locations

Country Name City State
France Centre Hospitalier de Boulogne-sur-Mer Boulogne-sur-Mer
France Centre Hospitalier Universitaire de Lille Lille

Sponsors (1)

Lead Sponsor Collaborator
Decathlon SE

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Functionnal score Comparison of the Patient Rated Elbow Evaluation (20-item questionnaire with a global score from 0=best outcome to 100=worst outcome) between the baseline and last follow-up visit in each group (orthosis vs control) Change from Baseline functionnal score at 6 weeks
Secondary Confidence level (confidence questionnaire related to physical activity) Gap in the confidence level related to physical activity (6-item questionnaire with a global score from 0=worst outcome to 100=best outcome), between the baseline and last follow-up visit in each group (orthosis vs control) Change from Baseline confidence level at 6 weeks
Secondary Elbow pain Comparison of elbow pain, assessed through a Numerical Rating Scale (NRS) ranging from 0=best outcome to 10=worst outcome, between the groups (orthosis vs control) Change from Baseline elbow pain at 6 weeks
Secondary Elbow instability Comparison of elbow instability, assessed through a Numerical Rating Scale (NRS) ranging from 0=best outcome to 10=worst outcome, between the groups (orthosis vs control) Change from Baseline elbow instability at 6 weeks
Secondary Safety (adverse events) Comparison of adverse events rates between the groups (orthosis vs control) 6 weeks of follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT05552209 - Assessment of the Safety and Performance of Elbow Supports in the Context of Epicondylitis or a Return to Sport After Sprain
Withdrawn NCT02861183 - Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow) N/A
Completed NCT02378285 - Treatment of Epicondylitis by Ultrasound-guided Local Injections of PRP (Platelet Rich Plasma) N/A
Not yet recruiting NCT05238090 - Efficacy of a Stretching Protocol for Lateral Epicondylitis N/A
Completed NCT03896204 - Effect of Telephone-supported Joint Protection Technique Training N/A
Completed NCT04729400 - Percutaneous Electrolysis and Vacuum Myofascial Therapy deviceTrial. N/A
Not yet recruiting NCT05872165 - Ozonated Gel Phonophoresis On Chronic Lateral Epicondylitis N/A
Completed NCT03225404 - Effectiveness of Percutaneous Electrolysis in the Treatment of Lateral Epicondylalgia. A Single-Blind Randomized Controlled Trial. N/A
Not yet recruiting NCT01269879 - VIBration Training in EpicondylitiS Phase 3
Active, not recruiting NCT01185951 - TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies Phase 2
Not yet recruiting NCT01273688 - Eccentric Training With or Without Elbow Brace for Epicondylitis Phase 3
Not yet recruiting NCT05853029 - Combined Shockwave Therapy Versus Focused Shockwave Therapy in Patients With Lateral Epicondylitis N/A
Completed NCT01945528 - Platelet Rich Plasma (PRP) in Chronic Epicondylitis Phase 3
Completed NCT03380559 - A Phase III Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis Phase 3
Completed NCT00382941 - Study of LED Phototherapy for Musculoligamentous Lesions N/A